Physician profile
Caitlin Colvard
NPI 1720411580
$760.88
in general payments reported to CMS, 2019-2025
13 companies · $62.11 in 2025
The $62.11 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $190 · 2020: $109 · 2021: $159 · 2022: $157 · 2023: $32.94 · 2024: $52.02 · 2025: $62.11.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $147.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $147.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cranial Technologies, INC | $143.13 | 2019-2023 | Doc Band |
| Takeda Pharmaceuticals U.S.A., INC. | $133.56 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $107.15 | 2020-2025 | Gardasil 9, Vaxneuvance, Rotateq |
| Pfizer INC. | $104.95 | 2019-2022 | |
| Genentech USA, INC. | $66.62 | 2019-2021 | |
| Supernus Pharmaceuticals, INC. | $49.73 | 2021 | |
| Sanofi Pasteur INC. | $40.65 | 2021-2024 | |
| Linvatec Corporation | $26.05 | 2025 | Biobrace 23mm |
| Kaleo, INC. | $20.45 | 2022 | |
| Shire North American Group INC | $19.19 | 2019 | |
| Vericel Corporation | $18.50 | 2025 | |
| Glaxosmithkline, LLC. | $17.05 | 2021 | |
| Mission Pharmacal Company | $13.85 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caitlin Colvard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.